Allakos Inc

Company Profile

Allakos Inc had its IPO on 2018-07-19 under the ticker symbol ALLK.

The company operates in the Healthcare sector and Biotechnology industry. Allakos Inc has a staff strength of 192 employees.

Stock update

Shares of Allakos Inc opened at $2.56 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.37 - $2.56, and closed at $2.38.

This is a -5.18% slip from the previous day's closing price.

A total volume of 935,896 shares were traded at the close of the day’s session.

In the last one week, shares of Allakos Inc have slipped by -23.72%.

Allakos Inc's Key Ratios

Allakos Inc has a market cap of $558.08 million, indicating a price to book ratio of 1.8517 and a price to sales ratio of 0.

In the last 12-months Allakos Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-315358016. The EBITDA ratio measures Allakos Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Allakos Inc’s operating margin was 0% while its return on assets stood at -43.75% with a return of equity of -84.65%.

In Q4, Allakos Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Allakos Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-6.07 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Allakos Inc’s profitability.

Allakos Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.9899. Its price to sales ratio in the trailing 12-months stood at 0.

Allakos Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$386.42 million

Total Liabilities

$30.04 million

Operating Cash Flow

$-71477000.00

Capital Expenditure

$291000

Dividend Payout Ratio

0%

Allakos Inc ended 2024 with $386.42 million in total assets and $0 in total liabilities. Its intangible assets were valued at $386.42 million while shareholder equity stood at $310.43 million.

Allakos Inc ended 2024 with $0 in deferred long-term liabilities, $30.04 million in other current liabilities, 85000.00 in common stock, $-932776000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $87.22 million and cash and short-term investments were $279.79 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Allakos Inc’s total current assets stands at $308.84 million while long-term investments were $0 and short-term investments were $192.57 million. Its net receivables were $0 compared to accounts payable of $4.83 million and inventory worth $0.

In 2024, Allakos Inc's operating cash flow was $-71477000.00 while its capital expenditure stood at $291000.

Comparatively, Allakos Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.38

52-Week High

$8.73

52-Week Low

$2.54

Analyst Target Price

$5.44

Allakos Inc stock is currently trading at $2.38 per share. It touched a 52-week high of $8.73 and a 52-week low of $8.73. Analysts tracking the stock have a 12-month average target price of $5.44.

Its 50-day moving average was $4.08 and 200-day moving average was $5.39 The short ratio stood at 3.68 indicating a short percent outstanding of 0%.

Around 418.5% of the company’s stock are held by insiders while 9184.7% are held by institutions.